Profilo
Ambarish Shah is Chief Technology Officer at DiaMedica Therapeutics, Inc. since 2023.
Formerly, Dr. Shah was Executive Director & Head-Drug Product Development at Bristol Myers Squibb Co. and Vice President & Head-Global Vaccines Development at Csl Seqirus.
Education includes a doctorate from Mercer University, a graduate degree from Duquesne University School of Law, and an undergraduate degree from the University of Mumbai.
Posizioni attive di Ambarish Shah
| Società | Posizione | Inizio |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 12/09/2023 |
Precedenti posizioni note di Ambarish Shah
| Società | Posizione | Fine |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Direttore/Membro del Consiglio | - |
Csl Seqirus | Corporate Officer/Principal | - |
Formazione di Ambarish Shah
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
DiaMedica Therapeutics, Inc.
DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Mercer University
Mercer University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duquesne University School of Law
Duquesne University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Csl Seqirus | Health Technology |
















